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WHY DOES EXERCISE “TRIGGER” ADAPTIVE PROTECTIVE RESPONSES IN 
THE HEART?
Rick J. Alleman, Luke M. Stewart, Alvin M. Tsang, and David A. Brown 
h  Department of Physiology and East Carolina Diabetes and Obesity Institute, 
Brody School of Medicine, East Carolina University, Greenville NC USA
h  Numerous epidemiological studies suggest that individuals who exercise have decreased 
cardiac morbidity and mortality. Pre-clinical studies in animal models also find clear car-
dioprotective phenotypes in animals that exercise, specifically characterized by lower 
myocardial infarction and arrhythmia. Despite the clear benefits, the underlying cellular 
and molecular mechanisms that are responsible for exercise preconditioning are not fully 
understood. In particular, the adaptive signaling events that occur during exercise to 
“trigger” cardioprotection represent emerging paradigms. In this review, we discuss recent 
studies that have identified several different factors that appear to initiate exercise precon-
ditioning. We summarize the evidence for and against specific cellular factors in triggering 
exercise adaptations and identify areas for future study.
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INTRODUCTION
The beneficial effects of exercise on the cardiovascular system have 
been well characterized over the last several decades and it is now accepted 
that exercise can be used as primary prevention for cardiovascular disease 
(Oberman 1985). Manifestations of cardiovascular disease are blunted 
with exercise in experimental animal models, and epidemiological data in 
humans further support these findings (Wang et al. 1993; Hamalainen et 
al. 1995). Exercise-induced protection against acute coronary syndromes 
encompasses a reduction in myocardial infarction (Brown et al. 2005b; 
Lee et al. 2012; Frasier et al. 2013), arrhythmia (Frasier et al. 2011b; Frasier 
et al. 2013), and stunning (Bowles et al. 1992; Taylor et al. 1999; Lennon et 
al. 2004; Taylor et al. 2007). While there is an abundance of literature on 
proposed mechanisms that seek to explain the protective effects of exer-
cise (Starnes and Taylor 2007; Frasier et al. 2011a; Lee et al. 2012), a large 
portion of this research focuses on end points of protection as well as the 
downstream signaling events that protect the myocardium.
During exercise, an increase in cardiac output is warranted so that the 
heart can meet the demands of exercising muscles. Aside from matching 
cardiac output with peripheral demand, exercise also induces precondi-
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tioning whereby the heart is more resistant to injury even long after the 
exercise has ceased. The proverbial “triggers” that induce cardioprotec-
tive signaling are clearly multi-factorial, and include neural, endocrine, 
and paracrine factors, as well as autocrine signaling and adaptations that 
arise from within the heart itself.
Exercise can be thought of as eustress; positive stress that a cell 
responds to in a way that allows it to better cope with that stressor. The 
adaptive mechanisms associated with exercise ultimately induce a car-
dioprotective phenotype, resulting in increased tolerance to metabolic 
stressors (i.e. ischemia). Proposed triggers of exercise cardioprotection 
include: adenosine, opioids, adenosine monophosphate-activated protein 
kinase (AMPK), cytokines, mitochondrial and cytosolic derived reactive 
oxygen species (ROS), nitric oxide (NO), and adrenergic signaling. This 
review will focus on studies investigating cardioprotection induced by 
acute aerobic exercise regimens (i.e. days, weeks, and months of training) 
at moderate to high intensity. The windows of protection include an early 
window that occurs within the first hour after exercise, and a late window 
that typically lasts from 24 to 72 hours (Yamashita et al. 1999; Brown et al. 
2003). Studies that utilize different exercise regimens or include protec-
tion outside of these time points will be described in detail. We will start 
by briefly discussing epidemiological findings in humans pertaining to 
exercise duration and disease risk prevention, and then shift the focus to 
the various biological compounds that are responsible for cardioprotec-
tion. The main objectives are: 1. To review the literature addressing the 
different factors that induce cardioprotective adaptive responses during/
after exercise, and 2. To shed light on gaps in the literature where future 
studies will advance the field. The first half of our review will focus on 
circulating factors released during exercise that converge on the heart, 
with the latter portion focusing on adaptations that occur within the heart 
during exercise.
What dose of exercise is needed for cardioprotection?
Although there are benefits of exercise across intensities, both epi-
demiological and animal studies suggest that moderate to high-intensi-
ty exercise is best for the heart. The dose-response aspect relating the 
quantity of exercise that results in a reduction in cardiovascular risk has 
been extensively investigated across a number of human epidemiological 
studies. In a longitudinal study Lee et al. (2000) tracked physical activity 
in 482 males (average 66 years of age) over a five year period and showed 
that energy expenditure was the key variable in reducing coronary heart 
disease risk. They found shorter intervals of exercise at a higher intensity 
provides the same protective benefit as longer intervals of exercise at a 
lower intensity, as long as the overall energy expenditures were equal. 
The study also supports the idea that exercise intensity is an important 
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determinant of cardioprotection following an acute exercise regimen 
(e.g. days to weeks), and that multiple small bouts of intense exercise 
may have the same net result as one extended bout of exercise. Mora et 
al. (2007) investigated differing levels of physical activity in a group of 
27,055 healthy women, determined by kcal/wk expended. They showed 
a dose-dependent relationship with 200-599, 600-1499 and >1500 kcal/wk 
groups having a 27%, 32% and 41% reduction in cardiovascular disease 
risk, respectively, compared to the baseline group which expended less 
than 200 kcal/wk. Although the authors acknowledged more research was 
necessary to determine the exact biological mechanisms that resulted in 
this protection, they found that the reduction in risk seen with increasing 
levels of physical activity can be explained in large part by a reduction in 
inflammatory/hemostatic biomarkers.
In animal studies, cardioprotection from I/R injury has been shown to 
occur after only a single bout of exercise and is sustainable if the exercise 
continues for many months (reviewed in (Frasier et al. 2011a; Quindry and 
Hamilton 2013)). The majority of our focus herein is on factors released 
during exercise itself. Long-term chronic exercise is likely a combination 
of acute factors (reaping the benefits of each individual exercise session) 
and additional adaptations that include shifted autonomic nervous system 
tone, heightened levels of cardioprotective proteins (described below), 
and beneficial hypertrophy. In terms of acute exercise, cardioprotec-
tion (reductions in myocardial infarction) is observed after moderately 
high-intensity exercise (>70% VO2 max) (Yamashita et al. 1999; Hoshida 
et al. 2002; Brown et al. 2003; French et al. 2008; Quindry et al. 2010b), 
consistent with the notion that higher intensity appears to be the most 
beneficial for the heart. In the following sections, we will describe the 
different factors released during exercise that initiate the protective phe-
notypic shift.
ADENOSINE
Adenosine is a purine nucleoside molecule that has been identified 
as a trigger of exercise-induced adaptations within the myocardium. 
Signaling occurs through four cell-surface receptors distributed heteroge-
neously throughout regions of the myocardium: adenosine A1, A2A, A2B, 
and A3 receptors (Fredholm et al. 2011). Adenosine receptor activation 
signals through G-protein coupled receptors (Gi, Gs, Go, and Gq) leading 
to the targeting of various downstream effectors and divergent regulation 
of cardiac function (Chandrasekera et al. 2010). During exercise cardiac 
adenosine levels rise proportional to increasing heart rate (Watkinson et 
al. 1979). A potential interplay between heart rate and adenosine release 
in exercise cardioprotection was demonstrated in dogs where the infarct 
salvage observed following intermittent bouts of tachycardia was abol-
ished with administration of an adenosine receptor blocker (Domenech 
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et al. 1998). Support for the cardioprotective effect of adenosine is also 
provided in non-exercise, non-I/R studies whereby treatment with ade-
nosine leads to the activation of endogenous antioxidant defense systems, 
and the adenosine receptor antagonist theophylline abolishes this effect 
(Maggirwar et al. 1994; Husain and Somani 2005). Similarly, adenosine 
receptor blockade during exercise exacerbates post-exercise oxidative 
stress biomarkers (Husain and Somani 2005). Taken together, these 
findings indicate that the increase in heart rate during exercise leads to 
a transient oxidative stress which is blunted through adenosine-induced 
upregulation of the antioxidant defense system. However, the intermedi-
ate signaling of adenosine that may be responsible for triggering exercise 
cardioprotection is less well defined. Non-exercise studies suggests that 
A1 receptor activation reduces infarct size by priming the opening of 
mitochondrial potassium adenosine triphosphate (mitoKATP) channels, 
presumably through a PKC mediated mechanism (Sato et al. 2000). One 
study demonstrated that opening of mitoKATP channels may play a role in 
the early phase of exercise cardioprotection, as the early window of pro-
tection was abolished with channel blockade during exercise (Domenech 
et al. 2002). However, exercise-induced mitoKATP channel activity has not 
been linked to adenosine signaling and merits further research before 
conclusions can be drawn. Therefore, these results suggest that transient 
increases in adenosine levels are important for ROS buffering during 
acute exercise, but whether or not this is due to opening of mitoKATP 
channels is not known. While cardiac adenosine signaling following exer-
cise seems to be important for the activation of redox networks, adenos-
ine has not been established as being solely responsible for the increase in 
antioxidant capacity. In addition, it is also unknown if adenosine receptor 
blockade during consecutive exercise bouts would mitigate the upregula-
tion in antioxidant defense systems.
One of the limitations in our understanding of adenosine as a trigger 
for exercise cardioprotection is the lack of knowledge pertaining to the 
specificity of adenosine receptor activation following exercise. As men-
tioned previously, there are four different adenosine receptors, and the 
specific subtypes activated following exercise has not been well character-
ized. For example, pharmacological blockade of adenosine receptors with 
theophylline is thought to inhibit signaling through A1 and A2A receptors 
(Jacobson et al. 2012). Theophylline is commonly used as an adenosine 
receptor blocker (Domenech et al. 1998; Husain and Somani 2005), but 
the specificity of its action and the downstream signaling events has not 
been tested in exercise-preconditioning studies. The use of non-specific 
pharmacological compounds is problematic from a mechanistic stand-
point because adenosine receptor activation elicits divergent effects 
depending on the subtype of receptors activated. Further, adenosine 
receptors possess the ability to dimerize with other subtypes (Fredholm 
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et al. 2011), leading to greater complexity in the biological actions of 
adenosine. Nonetheless, adenosine appears to exert a substantial effect 
on cardiac physiology and pathophysiology, but more research is needed 
to solidify adenosine as a required trigger for exercise cardioprotection.
OPIOIDS
Opioids are another cell-surface signaling molecule that can trigger 
a protective phenotype. Endorphins, enkephalins, and dynorphins pre-
dominately signal through μ-, δ-, and κ-opioid receptors respectively, 
each with various subtypes distributed centrally and peripherally (van den 
Brink et al. 2003). Pharmacological activation of κ- and δ-opioid receptors 
reduces infarct size, with a ‘second window of preconditioning’ similar to 
what is seen with exercise (Schultz et al. 1998; Fryer et al. 1999). Opioid-
mediated signaling occurs throughout the nervous system, and there is 
evidence that striated muscle can produce preproenkephalin mRNA and 
peptide products (Springhorn and Claycomb 1989; Weil et al. 2006).
Several studies have examined opioids following exercise. A ten-fold 
increase in overall serum opioid activity immediately following exhaus-
tive exercise has been observed in human (Rahkila et al. 1988; Schwarz 
and Kindermann 1992) and rodent models (Debruille et al. 1999), with 
release of various endorphins being most prominent following high-in-
tensity exercise (>90% VO2max). These data are particularly interesting 
from a dose-response standpoint, as the opioid release occurred following 
near-maximal exercise, and many studies find benefit after sub-maximal 
exercise regimens (Brown et al. 2005a; Brown and Moore 2007; Calvert 
et al. 2011; Frasier et al. 2011a; Taylor and Starnes 2012; Quindry and 
Hamilton 2013; Powers et al. 2014).
Further support for the role of opioids in exercise-induced cardio-
protection comes from studies examining blood-borne factors. Michelsen 
et al. (2012) recently observed infarct size reductions in isolated rabbit 
hearts that were perfused with human plasma dialysates conditioned by 
acute high-intensity exercise. Co-perfusion with a non-specific opioid 
antagonist reduced the infarct sparing effect (Michelsen et al. 2012), 
which is consistent with other studies where pre-exercise administration 
of the non-specific opioid antagonist naloxone/naltrexone abolished 
protection afforded by a 12-week exercise regimen (Dickson et al. 2008; 
Galvao et al. 2011).
Like adenosine mediated protection, there is evidence that opioid 
signaling also acts through the mitoKATP channel. In non-exercise studies, 
protection observed following opioid receptor activation is abolished with 
the mitoKATP blocker 5-HD (Fryer et al. 1999). Administration of 5-HD 
prior to I/R also abolishes the anti-arrhythmic effect of exercise, but opi-
oid levels were not measured (Quindry et al. 2010b). However, unlike ade-
nosine-mediated protection, opioid signaling may not exert its protective 
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effects through the upregulation of antioxidant defense systems. Twenty-
four hours after a five-day exercise regimen, mRNA levels of opioid pre-
cursors and receptors increased in unstressed hearts while there was no 
change in superoxide dismutase, HSPs, or catalase (Dickson et al. 2008). 
Even though these specific antioxidant gene transcripts did not change, 
enhanced ROS buffering cannot be ruled out because antioxidant capac-
ity was not comprehensively analyzed. Although we are still early in our 
understanding of how opioids are influencing exercise cardioprotection, 
these preliminary studies provide rationale for their release and biological 
activity following exercise.
CYTOKINES
Cytokine production during exercise is another putative triggering 
mechanism of exercise cardioprotection that has received less attention 
from the scientific community. During exercise contracting muscle acts 
as an endocrine organ by secreting various cytokines that can facilitate 
downstream biological actions (Donges et al. 2014). In non-exercise stud-
ies, early work demonstrated a cardioprotective role for cytokines in I/R 
injury that involved lower oxidative stress during the reperfusion period 
(Brown et al. 1990; Eddy et al. 1992). Subsequent studies by Yamashita et 
al. (1999) sought to determine how exercise-induced cytokine produc-
tion influenced infarct salvage. They demonstrated that administration of 
TNF-α and IL-1 antibodies prior to a single exercise bout abolished the 
early- and late-windows of cardioprotection. However, aside from the car-
dioprotective effects that cytokines can exert on the myocardium, there 
are deleterious effects as well. The discrepant findings in the literature 
regarding adverse and cardioprotective actions of cytokines on I/R has 
been reviewed (Saini et al. 2005). The cardioprotective action of cytokines 
appears to occur at lower concentrations, whereas higher concentrations 
may exert harmful effects. Moving forward more research is needed to 
uncover the divergent roles of cytokines on myocardial physiology before 
they can be implemented as therapeutic agents for I/R injury.
ADRENERGIC SIGNALING
The role of adrenergic receptor stimulation during exercise has 
become recognized as a part of exercise-induced cardioprotection. In 
response to systemic demand, β-adrenergic stimulation increases cardi-
ac chronotropy, inotropy and lusitropy (reviewed in (Steinberg 1999)). 
These effects are mainly attributed to the β1-adrenergic receptor which is 
the predominant isoform in the heart, but β3-adrenergic receptors appear 
to play a contradictory role, as stimulation leads to a negative inotropic 
response (Tavernier et al. 2003; Napp et al. 2009). The negative inotropic 
effect is mediated through downstream activation of eNOS (Gauthier et 
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al. 1998). However, the existence of a functional β3-adrenergic receptor in 
the human heart has recently been called into question due to the lack of 
selectivity of pharmacological tools used to study its function and expres-
sion (reviewed in (Michel et al. 2011)). Nonetheless, it has been postulat-
ed that β-adrenergic stimulation may trigger exercise cardioprotection by 
increasing NO bioavailability. β-adrenergic stimulation of cardiac tissue 
via the sympathetic nervous system has been shown to be important in 
triggering the protective phenotype, as ablation of the cardiac sympathet-
ic nerve with topical application of phenol abolishes the infarct salvage 
afforded by seven days of exercise in mice (Akita et al. 2007). The authors 
attributed these effects to a decrease in eNOS activity because an increase 
in eNOS phosphorylation was not observed in mice with cardiac sympa-
thetic nerve ablation, but was increased with exercise alone. Interestingly, 
the transient oxidative stress observed with exercise was also absent with 
cardiac sympathetic nerve ablation, indicating interplay between adren-
ergic stimulation, NO, and ROS in exercise cardioprotection. In another 
study Calvert et al. (2011) also demonstrated that adrenergic receptors 
play an important role in exercise cardioprotection via interaction with 
the NOS isoforms. Plasma catecholamine and β3-adrenergic receptor den-
sity increased following four weeks of voluntary wheel running, with no 
changes in the β1 and β2 isoforms. The cardioprotection against myocardi-
al infarction observed in the voluntary wheel running mice was abolished 
in β3-adrenergic receptor deficient mice. Similar to the previous study 
that linked adrenergic signaling to increased eNOS phosphorylation, 
eNOS phosphorylation as well as cardiac NO metabolites were depressed 
in β3-adrenergic receptor deficient mice exposed to voluntary wheel run-
ning. These findings implicate adrenergic signaling as a triggering mech-
anism during exercise. In this regard, Calvert et al. (2011) demonstrated 
that a single epinephrine bolus increased eNOS phosphorylation and 
heart NO metabolites. Importantly, infarct salvage following voluntary 
wheel running was lost when NO metabolites returned to normal levels 
after four weeks of exercise cessation. Taken together, there is strong evi-
dence for a role of adrenergic signaling in the triggering phase of exercise 
cardioprotection and the subsequent upregulation of NO bioavailability. 
However, more research is needed to fully characterize the specific role 
of β3-adrenergic receptor stimulation in NOS activation, especially in light 
of the fact that β2-adrenergic receptor activation has also been shown to 
be cardioprotective and can increase eNOS activity and NO metabolites 
(Bhushan et al. 2012).
NITRIC OXIDE
NO was initially thought to act only through local mediation of 
vasodilation due to its short half-life and high reactivity with biological 
substrate (Liu et al. 1998). However, more recent work implicates NO in 
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downstream mechanisms distant from the site of production (Calvert et 
al. 2011; Chouchani et al. 2013; Farah et al. 2013), as well as in cardiac 
myocytes themselves (reviewed in (Bloch et al. 2001)). During exercise, 
blood flow and vascular shear stress are elevated in tissue beds with high 
metabolic activity, which leads to the activation of endothelial nitric oxide 
synthase (eNOS) and heightened release of NO (Wang et al. 1993; Sessa 
et al. 1994; Zhang et al. 2009; Barbosa et al. 2013). NO metabolites such 
as nitrite, nitrate, and nitrosothiols were once thought of as inert, but are 
now widely accepted as storage forms of NO that undergo inter-conversion 
to exert biological effects (Zweier et al. 1995; Webb et al. 2004; Bryan et al. 
2005; Calvert et al. 2011). In non-exercise studies, the molecular reduction 
of nitrite to NO and nitrosothiols during I/R is cardioprotective (Webb 
et al. 2004; Bryan et al. 2007; Chouchani et al. 2013), which indicates that 
an increase in NO bioavailability may be an important determinant of 
exercise-induced cardioprotection.
Following exercise, there is an increase in eNOS activation and NO 
metabolites (Akita et al. 2007; Calvert et al. 2011), and when eNOS is 
genetically knocked out, the infarct sparing effects after seven days of 
exercise is abolished (Akita et al. 2007). The study also demonstrated that 
upregulation of eNOS during exercise was necessary for the subsequent 
increased activity of inducible NOS (iNOS) and the downstream infarct 
sparing effect of exercise (Akita et al. 2007). Others have observed an 
increase in iNOS activity following an acute bout of exercise, and when 
an iNOS inhibitor was administered prior to I/R the antiarrhythmic 
effect of exercise was abolished (Babai et al. 2002). However, the role of 
iNOS in exercise cardioprotection has been called into question due to 
the interspecies variability in expression patterns and a lack of increase 
following various exercise regimens (Quindry et al. 2010a; Calvert et al. 
2011). More recently Farah et al. (2013) demonstrated a role for eNOS in 
exercise cardioprotection in rats after five weeks of training. Following the 
exercise regimen, phosphorylation of eNOS and levels of s-nitrosylated 
proteins and nitrite were increased in the exercise group. Perfusion with 
a global NOS inhibitor prior to and immediately after I/R abolished the 
infarct sparing and mechanical recovery observed with exercise. They also 
demonstrated that eNOS uncoupling during the reperfusion period was 
required for the cardioprotection. However, not all groups demonstrate 
an essential role for NO in exercise cardioprotection. Taylor et al. (2007) 
administered a global NOS inhibitor prior to two days of exercise with the 
idea that cardioprotection would be lost. However, the beneficial effects 
of exercise on mechanical recovery and LDH release after I/R in rats were 
not different than with exercise alone (Taylor et al. 2007). The main dif-
ference in these studies is the timing of NOS inhibition (before exercise 
vs before I/R), and the duration of the exercise regimen. The study by 
Taylor et al. (2007) provides evidence against a role for NO production 
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during exercise as a triggering mechanism for cardioprotection. However, 
NO production during exercise may not be responsible for cardiopro-
tection per se, rather the increase in NO bioavailability and increase in 
eNOS activation (phosphorylation) seems to be more important in the 
cardioprotective phenotype. A mechanism whereby NO production can 
increase after exercise has been demonstrated. Following acute exercise, 
circulating bradykinin levels increase (Blais et al. 1999), stimulating the 
production of NO and NO metabolites (Zhou et al. 2010). Furthermore, 
bradykinin has been demonstrated to mediate its anti-arrhythmic effects 
through liberation of NO during I/R (Vegh and Parratt 2005). Given the 
discrepant findings, a few questions are left that need to be addressed 
moving forward: What is the locus of NO production that leads to an 
increase in NO metabolites (endothelium vs cardiac myocytes)? What are 
the temporal characteristics of NO production during and/or following 
exercise? When precisely does the cardioprotective phenotype become 
evident? In response to the latter, most studies indicate that storage 
forms of NO precipitate their cardioprotective effects during reperfu-
sion. Clearly more work is needed to definitively determine the role of 
NO production during/after exercise and how this affects NO metabolite 
accumulation en route to cardioprotection.
ADENOSINE MONOPHOSPHATE-ACTIVATED PROTEIN KINASE
Cardiac myocytes are densely packed with mitochondria in order to 
support cellular energetic requirements. In the healthy heart, the height-
ened rate of ATP hydrolysis during exercise increases mitochondrial 
respiration, ultimately allowing healthy myocytes to efficiently match ATP 
generation to cardiac workload. While cellular ATP:ADP ratios remain 
constant, AMP levels are thought to rise with increasing exercise intensi-
ty, leading to the activation of AMPK in cardiac muscle (Frederich and 
Balschi 2002; Coven et al. 2003). In this context, the activation of AMPK 
stimulates catabolic processes and down regulates anabolism allowing the 
cell to regulate metabolism for the production of ATP (Coven et al. 2003). 
AMPK has been deemed as one of the energy sensors of the cell and its 
activity increases by phosphorylation within 10 minutes of the onset of 
moderate and high intensity exercise (Coven et al. 2003). AMPK has also 
been shown to be important in post-ischemic cardiac injury, with exacer-
bated injury in transgenic mice expressing a dominant negative kinase 
dead α subunit of AMPK (Russell et al. 2004). Canonical AMPK signaling 
increases glucose and lipid oxidation, which is essential for replenishing 
ATP following an ischemic period.
In addition to increasing catabolism, AMPK has been shown to play a 
role in ischemic preconditioning by regulating sarcolemmal KATP channel 
trafficking and activity (Sukhodub et al. 2007). These studies suggest an 
important role for AMPK activity following ischemia/reperfusion (I/R), 
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but the extent to which AMPK influences exercise cardioprotection has 
received less attention. Although studies have consistently shown that 
exercise increases the phosphorylation of AMPK (Coven et al. 2003; 
Ogura et al. 2011), AMPK has not been shown to be crucial for exercise 
adaptations. Similar levels of exercise can be attained in transgenic mice 
expressing a cardiac-specific dominant-negative AMPKα2 subunit (Musi et 
al. 2005). Following 30 minutes of exercise, transgenic mice had similar 
cardiac glycogen and ATP levels as wild-type controls. A similar metabolic 
profile between the wild type and transgenic mice indicates that AMPK 
may not be crucial for enhanced cardiac metabolism, and that other over-
lapping pathways can help meet energy requirements during increased 
demand. Although AMPK is an attractive target for the cell to regulate 
its energy needs during metabolic stress, there is a gap in the literature 
linking exercise-induced AMPK activation with cardioprotection. More 
research is required to definitively determine if/how exercise influences 
AMPK activity in the heart, and whether or not these changes modify 
cardioprotection.
REACTIVE OXYGEN SPECIES
Cardiac ROS are another potential candidate involved in exercise 
cardioprotection, as well as other preconditioning stimuli such as isch-
emic and pharmacological preconditioning (Garlid et al. 2013). A large 
body of literature suggests that exercise induces a transient oxidative 
stress that leads to upregulation in antioxidant defense systems; however 
the locus of ROS production and downstream effectors during exercise 
remains unclear. In this section we will focus on evidence for the role of 
mitochondrial ROS in exercise cardioprotection, and cytosolic ROS in the 
following section.
ROS have received considerable attention in the cardiac literature due 
to their role in pathologies like I/R injury, heart failure, and cardiomy-
opathies. However, a growing body of literature suggests that ROS exert 
hormesis, where transient bursts of ROS leads to favorable adaptive redox 
signaling. Cellular ROS can act as second messengers in downstream 
signaling by altering the activity of redox sensitive enzymes throughout 
the cytosol and/or mitochondria of cardiac myocytes (Sadoshima 2006). 
Similar mechanisms may occur when transient bursts of ROS are gener-
ated during exercise (Bolli 1988; Hamilton et al. 2004; Dabkowski et al. 
2008). Following acute exercise there is an alteration in cellular redox 
status towards a more oxidized environment which may act as a signal to 
activate endogenous protective mechanisms (Nelson et al. 2011; Frasier et 
al. 2013).
There is general consensus that an increase in antioxidant enzymes is 
responsible for a large portion of exercise cardioprotection, and transient 
oxidative stress with exercise may play a role in this adaptation. Evidence 
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for this has been provided by several groups who have observed increas-
es in key antioxidant enzymes following exercise (Yamashita et al. 1999; 
Demirel et al. 2001; Hamilton et al. 2001; Quindry et al. 2010b; Frasier 
et al. 2011b; Lee et al. 2012; Frasier et al. 2013). Studies in favor of this 
hypothesis have shown that administration of antioxidants prior to exer-
cise abolishes infarct salvage (Yamashita et al. 1999; Akita et al. 2007) and 
prevents exercise-induced improvements in cardiac performance (Nelson 
et al. 2011). However, another study indicated that ROS generated during 
exercise were not required for functional recovery following I/R (Taylor 
and Starnes 2012). The antioxidant frequently used in these studies was 
N-(2-mercaptopropionyl)glycine) (MPG), which was administered intra-
peritoneally 10-30 minutes prior to exercise. An important note to con-
sider is that MPG has been shown to have higher specificity for hydroxyl 
radicals rather than hydrogen peroxide (H2O2) and superoxide (Bolli 
et al. 1989), indicating that not all ROS signaling is abolished with treat-
ment. In addition, MPG has a plasma half-life of approximately 7 minutes 
(Horwitz et al. 1994), making it difficult to interpret how effective the 
treatment was at scavenging ROS during hour-long exercise bouts. These 
methodological differences make it difficult to directly compare their 
results (i.e. differences in species, duration of I/R, duration of exercise, 
measurement of injury, the timing of the administration of antioxidants, 
and in vivo versus ex vivo experiments).
Mitochondrial ROS
ROS signaling is a highly regulated and localized process, implying 
that the origin of ROS generated during exercise may be extremely 
important. Although mitochondrial ROS are thought to play a central 
role in ischemic preconditioning (Baines et al. 1997; Pain et al. 2000; 
Kloner and Jennings 2001), there is a paucity of evidence suggesting a 
role in exercise preconditioning. Frasier et al. (2013) recently found that 
the locus of ROS production during exercise is not mitochondrial in 
origin. As shown in Figure!1, exercise cardioprotection was not lost when 
administering agents that reduce mitochondrial ROS prior to exercise 
(mito TEMPO and Bendavia). This indicates that extramitochondrial-de-
rived ROS may be responsible for redox signaling following exercise.
Monoamine oxidase-A (MAO-A) is another potential site for mito-
chondrial ROS production. MAO-A is located on the outer mitochondrial 
membrane and catalyzes the oxidative deamination of neurotransmit-
ters such as norepinephrine and serotonin while generating H2O2 as a 
byproduct in the reaction. A recent review highlights the importance of 
MAO-A in pathological states such as heart failure and I/R (Kaludercic et 
al. 2011). Accumulation of serotonin released by platelets during I/R can 
lead to the production of H2O2 and subsequent apoptotic signaling cas-
cades (Bianchi et al. 2005). Recent findings indicate that exercise leads to 
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down-regulation of MAO-A (Kavazis et al. 2009), which may play a role in 
the attenuation of I/R damage associated with exercise cardioprotection. 
Moreover, these findings indicate that there is likely a reduction in mito-
chondrial ROS production with exercise, given the decrease in MAO-A 
expression and increases in the activity of key antioxidants such as MnSOD 
and glutathione reductase (GR) (Quindry et al. 2010b; Frasier et al. 2013). 
A decrease in cardiac mitochondrial MAO-A would theoretically dampen 
the oxidative burden imposed on the cell, not only during exercise, but 
also during thrombus formation and subsequent I/R injury. A mecha-
nism for the decrease in MAO-A expression following exercise has not 
been investigated and therefore the triggering event for this adaptation is 
purely speculative. Perhaps acute increases in cardiac sympathetic nerve 
stimulation and increasing norepinephrine levels during exercise play a 
role in downstream silencing of MAO-A through non-canonical adrener-
gic pathways (Vidal et al. 2012). Cardiac sympathetic stimulation increases 
contractility and myocardial stretch during exercise, which in and of itself 
may trigger a cardioprotective phenotype through elevated cytosolic ROS 
production (Frasier et al. 2013; Ward et al. 2014). Furthermore, cardiac 
sympathetic nerve ablation has been shown to abolish the infarct sparing 
effect of exercise, but this was not linked to silencing of MAO-A expres-
sion (Akita et al. 2007). A hypothetical adrenergic/MAO-A axis scenario 
opens up an exciting area of research to explore mechanisms controlling 
MAO-A expression in cardiac tissue during normal physiological as well 
as pathophysiological states. We will further expand on the topic of 
stretch-induced activation of cardioprotection in the next section.
FIGURE 1. Reductions in infarct size are abolished by inhibiting NADPH Oxidase (with pre-exercise 
treatment of apocynin or Vas2870) during exercise. Inhibition of mitochondrial ROS during exercise 
(with pre-exercise administration of TEMPO or the mitochondria-targeting peptide Bendavia) had 
no effect on exercise cardioprotection. Figure reproduced from Frasier et al., Cardiovascular Research 
2013, with permission (pending).
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Cytosolic ROS
Free-radical generating enzyme systems outside of the mitochondria 
have also received considerable interest in normal physiology as well as 
in pathological states such as I/R injury (McCord 1985; Bolli 1988; Misra 
et al. 2009) and heart failure (Tsutsui et al. 2011; Harzand et al. 2012). 
Sources of extramitochondrial-derived ROS in cardiac myocytes include 
xanthine oxidase, NADPH oxidase, and uncoupled nitric oxide synthase. 
Of these, the NADPH oxidase (NOX2 in particular) complex gener-
ates ROS in a highly localized manner in the sarcolemmal and t-tubule 
membranes during physiological stretch (Sanchez et al. 2008; Prosser et 
al. 2011). Myocardial contraction and wall stress increases during exer-
cise as a function of heart rate and adrenergic signaling. The increased 
inotropic and chronotropic state is an autoregulatory mechanism that 
allows for tight regulation of blood pressure and delivery of nutrients to 
metabolically active tissue. Recent work indicates that the sarcolemmal 
NOX2-generated ROS system plays a central role in this phenomenon. 
NOX2-generated ROS imposes redox signaling through ryanodine recep-
tors leading to increased calcium release and subsequent contractile activ-
ity (Sanchez et al. 2008; Donoso et al. 2014). Stretch induction through 
the microtubule network and NOX2 activation has been termed X-ROS 
signaling (Prosser et al. 2011). X-ROS signaling describes the transfer of 
a mechanical to a chemical signal throughout the heart via the microtu-
bule system, leading to assembly of the NOX2 ROS generating complex. 
Recently, several independent groups have established a role for NOX2 
as a potential trigger for the cardioprotective phenotype associated with 
exercise (Sanchez et al. 2008; Frasier et al. 2013).
As mentioned previously, a critical threshold of exercise intensity 
appears to be important for cardioprotection, and at higher exercise 
intensities myocardial contraction increases in conjunction. In line with 
the X-ROS signaling hypothesis, increased inotropy and myocardial stretch 
during exercise may lead to activation of NOX2 and perhaps downstream 
adaptations. We and others have demonstrated that inhibition of NOX2 
prior to exercise abolishes the infarct salvage of early and late phases 
of exercise cardioprotection (Sanchez et al. 2008; Frasier et al. 2013). 
Furthermore, the upregulation of GR activity that is typically observed fol-
lowing exercise (Venditti and Di Meo 1996; Ramires and Ji 2001; Kakarla 
et al. 2005; Frasier et al. 2011b) is also abolished immediately and 24 hours 
after the exercise bout when NOX2 is inhibited during exercise (Frasier 
et al. 2013). GR is a central enzyme involved in cellular redox control by 
utilizing NADPH to convert oxidized glutathione to the reduced form. 
Therefore, increasing GR activity allows the cell to maintain the glutathi-
one pool in the reduced state, thus providing a greater buffering power 
during oxidative insults. During an exercise bout mechanical stretch of 
the myocardium increases, leading to NOX2-generated ROS and activa-
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tion of GR (Frasier et al. 2013). ROS signaling through GR may be a mech-
anism where GR acts as a sensor during oxidative shifts of the redox envi-
ronment, leading to upregulation of endogenous defense systems. Future 
studies examining the time frame of GR activation and sustainability of 
protection will shed light on signaling between NOX2 and GR during 
the cardioprotective window of exercise. Also, studies that determine the 
importance of GR compartmentalization are warranted, particularly with 
regard to cytosolic and/or mitochondrial GR pools involved in this adap-
tive signaling network (Kang et al. 2014). While it seems apparent that 
exercise upregulates redox buffering capacity, more research is needed 
to definitively determine if transient bursts of ROS during exercise act as 
a signal to trigger downstream cardioprotection.
CONCLUSIONS
We have described a number of circulating and intrinsic factors pos-
tulated to induce cardioprotective signaling with exercise. These factors 
converge on the myocardium, and result in downstream adaptations that 
characterize the protective phenotype. Subsequent investigation into 
these downstream effects using novel approaches will greatly advance 
the field. For example, ROS production during exercise is an intriguing 
factor that leads to both post-translational modifications to existing pro-
teins in the short-term, as well as altered protein expression on a longer 
time-scale. Given that 21,000 to 42,000 thiols in the proteome can con-
tribute to the integration of metabolic function through redox signaling 
(Jones 2008), further exploration of the redox hypothesis in the context 
of exercise adaptations is warranted. The convergent effects of cellular 
ROS production and elevated levels of cell-signaling molecules such as 
adenosine, NO, cytokines, and catecholamines during elevated workloads 
transduce the exercise stimulus that culminates into a hormetic cardiac 
response. Inhibition of any one of these putative triggers can dampen the 
cardioprotective phenotypic switch observed with exercise, but ultimately 
these adaptations lead to tolerance to I/R injury characterized by lower 
arrhythmia and decreased myocardial infarction. Given that exercise is 
known to confer protection in humans, future studies that continue to 
advance our understanding of the intrinsic factors responsible for evoking 
this protective phenotype may ultimately pave the way for novel therapies 
to reduce the burden of acute coronary syndromes.
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